mometasone cipla 50 mikrogramm/adag szuszpenziós orrspray
cipla europe nv - expozíció -
mometason sandoz 1 mg/g kenőcs
sandoz hungária kft. - expozíció -
mometasone reig jofre 1 mg/g krém
laboratorio reig jofre, s.a. - mire furoate -
mometason sandoz 50 mikrogramm/adag szuszpenziós orrspray
sandoz hungária kft. - expozíció -
mometason pannonpharma 50 mikrogramm/adag szuszpenziós orrspray
pannonpharma kft. - mire furoate -
nasotasone 50 mikrogramm/adag szuszpenziós orrspray
teva gyógyszergyár zrt. - mire furoate -
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - asztma - gyógyszerek obstruktív légúti betegségek, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - asztma - gyógyszerek obstruktív légúti betegségek, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - asztma - gyógyszerek obstruktív légúti betegségek, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - asztma - gyógyszerek obstruktív légúti betegségek, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.